NL6810011A - - Google Patents
Info
- Publication number
- NL6810011A NL6810011A NL6810011A NL6810011A NL6810011A NL 6810011 A NL6810011 A NL 6810011A NL 6810011 A NL6810011 A NL 6810011A NL 6810011 A NL6810011 A NL 6810011A NL 6810011 A NL6810011 A NL 6810011A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring
- C07F9/65505—Phosphonic acids containing oxirane groups; esters thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
- Y10S435/896—Streptomyces fradiae
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65575767A | 1967-07-25 | 1967-07-25 | |
| US67916567A | 1967-10-30 | 1967-10-30 | |
| US72805968A | 1968-05-09 | 1968-05-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL6810011A true NL6810011A (en:Method) | 1969-01-28 |
| NL143130B NL143130B (nl) | 1974-09-16 |
Family
ID=27417948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL686810011A NL143130B (nl) | 1967-07-25 | 1968-07-15 | Werkwijze ter bereiding van tegen bacterien werkzame preparaten en werkwijze ter bereiding van een antibioticum. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3639590A (en:Method) |
| AT (1) | AT290011B (en:Method) |
| BE (1) | BE718507A (en:Method) |
| CH (1) | CH521440A (en:Method) |
| DE (1) | DE1768965B1 (en:Method) |
| DK (1) | DK124336B (en:Method) |
| ES (1) | ES356487A1 (en:Method) |
| FI (1) | FI45863C (en:Method) |
| FR (2) | FR7683M (en:Method) |
| GB (1) | GB1223923A (en:Method) |
| IL (1) | IL30384A (en:Method) |
| IT (1) | IT1008508B (en:Method) |
| LU (1) | LU56580A1 (en:Method) |
| MT (1) | MTP565B (en:Method) |
| NL (1) | NL143130B (en:Method) |
| NO (1) | NO127758B (en:Method) |
| SE (1) | SE367020B (en:Method) |
| YU (1) | YU33669B (en:Method) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3873547A (en) * | 1973-05-02 | 1975-03-25 | Merck & Co Inc | The salt of 3-nitro-9-aminoacridine and -(cis)-1,2-epoxypropylphosphonic acid |
| IT1112282B (it) * | 1978-07-19 | 1986-01-13 | Zambon Spa | Bis-(2-ammonio-2-idrossimetil-1,3-propandiolo)(2r-cis)-(3-metilossiranil)fosfonato |
| IT1124610B (it) * | 1979-10-18 | 1986-05-07 | Zambo Spa | Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato |
| US4482488A (en) * | 1982-09-27 | 1984-11-13 | Eli Lilly And Company | Antibiotic A53868 and process for production thereof |
| US4463092A (en) * | 1982-09-27 | 1984-07-31 | Eli Lilly And Company | Process for production antibiotic A53868 |
| IT1212777B (it) * | 1983-10-07 | 1989-11-30 | Seuref Ag | Antibiotica. composto ad attivita' |
| CH660306A5 (de) * | 1984-10-05 | 1987-04-15 | Schering Spa | Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2895952A (en) * | 1955-04-21 | 1959-07-21 | Merck & Co Inc | Purification of novobiocin |
-
1968
- 1968-05-09 US US728059A patent/US3639590A/en not_active Expired - Lifetime
- 1968-07-15 NL NL686810011A patent/NL143130B/xx not_active IP Right Cessation
- 1968-07-17 IL IL30384A patent/IL30384A/xx unknown
- 1968-07-18 CH CH1076568A patent/CH521440A/de not_active IP Right Cessation
- 1968-07-18 DE DE19681768965 patent/DE1768965B1/de active Pending
- 1968-07-18 MT MT565A patent/MTP565B/xx unknown
- 1968-07-22 GB GB34781/68A patent/GB1223923A/en not_active Expired
- 1968-07-22 IT IT38604/68A patent/IT1008508B/it active
- 1968-07-23 FI FI682082A patent/FI45863C/fi active
- 1968-07-23 AT AT712668A patent/AT290011B/de not_active IP Right Cessation
- 1968-07-24 BE BE718507D patent/BE718507A/xx not_active IP Right Cessation
- 1968-07-24 ES ES356487A patent/ES356487A1/es not_active Expired
- 1968-07-24 YU YU1763/63A patent/YU33669B/xx unknown
- 1968-07-24 NO NO02917/68A patent/NO127758B/no unknown
- 1968-07-24 SE SE10074/68A patent/SE367020B/xx unknown
- 1968-07-24 DK DK357368AA patent/DK124336B/da not_active IP Right Cessation
- 1968-07-24 LU LU56580D patent/LU56580A1/xx unknown
- 1968-07-25 FR FR160544A patent/FR7683M/fr not_active Expired
- 1968-07-25 FR FR1574556D patent/FR1574556A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| YU33669B (en) | 1977-12-31 |
| GB1223923A (en) | 1971-03-03 |
| NL143130B (nl) | 1974-09-16 |
| DK124336B (da) | 1972-10-09 |
| FR7683M (en:Method) | 1970-02-16 |
| CH521440A (de) | 1972-04-15 |
| IT1008508B (it) | 1976-11-30 |
| BE718507A (en:Method) | 1969-01-24 |
| LU56580A1 (en:Method) | 1969-05-16 |
| NO127758B (en:Method) | 1973-08-13 |
| MTP565B (en) | 1969-09-22 |
| AT290011B (de) | 1971-05-10 |
| IL30384A (en) | 1973-01-30 |
| IL30384A0 (en) | 1968-09-26 |
| FI45863B (en:Method) | 1972-06-30 |
| FI45863C (fi) | 1972-10-10 |
| FR1574556A (en:Method) | 1969-07-11 |
| SE367020B (en:Method) | 1974-05-13 |
| US3639590A (en) | 1972-02-01 |
| ES356487A1 (es) | 1970-10-16 |
| YU176368A (en) | 1977-06-30 |
| DE1768965B1 (de) | 1971-12-23 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SNR | Assignments of patents or rights arising from examined patent applications |
Owner name: COMPANIA ESPANOLA DE PENICILINA Y ANTIBIOTICOS, S. |
|
| NL80 | Information provided on patent owner name for an already discontinued patent |
Owner name: MERCK |
|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |